FI66023C - Foerfarande foer framstaellning av nya anti-inflammatoriskt vekande 11beta-hydroxisteroider - Google Patents

Foerfarande foer framstaellning av nya anti-inflammatoriskt vekande 11beta-hydroxisteroider Download PDF

Info

Publication number
FI66023C
FI66023C FI790240A FI790240A FI66023C FI 66023 C FI66023 C FI 66023C FI 790240 A FI790240 A FI 790240A FI 790240 A FI790240 A FI 790240A FI 66023 C FI66023 C FI 66023C
Authority
FI
Finland
Prior art keywords
dione
pregnene
hydroxy
methyl
hours
Prior art date
Application number
FI790240A
Other languages
English (en)
Finnish (fi)
Other versions
FI66023B (fi
FI790240A (fi
Inventor
Ernst Schoettle
Alfred Weber
Mario Kennecke
Helmut Dahl
Joachim-Friedrich Kapp
Hans Wendt
Klaus Annen
Henry Laurent
Rudolf Wiechert
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19782803661 external-priority patent/DE2803661A1/de
Priority claimed from DE19782855465 external-priority patent/DE2855465A1/de
Application filed by Schering Ag filed Critical Schering Ag
Publication of FI790240A publication Critical patent/FI790240A/fi
Priority to FI812982A priority Critical patent/FI70718C/fi
Application granted granted Critical
Publication of FI66023B publication Critical patent/FI66023B/fi
Publication of FI66023C publication Critical patent/FI66023C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0053—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa not substituted in position 16
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0061—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16
    • C07J5/0069—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
    • C07J5/0076—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group by an alkyl group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0061—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16
    • C07J5/0069—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
    • C07J5/0084—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group by an alkylene group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C07J7/001—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
    • C07J7/004—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa
    • C07J7/0045—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa not substituted in position 16
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/008—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21
    • C07J7/0085—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21 by an halogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/001—Oxiranes
    • C07J71/0015—Oxiranes at position 9(11)
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/911—Microorganisms using fungi

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FI790240A 1978-01-25 1979-01-25 Foerfarande foer framstaellning av nya anti-inflammatoriskt vekande 11beta-hydroxisteroider FI66023C (fi)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FI812982A FI70718C (fi) 1978-01-25 1981-09-24 Foerfarande foer framstaellning av nya terapeutiskt anvaendbara kortikoider

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE2803661 1978-01-25
DE19782803661 DE2803661A1 (de) 1978-01-25 1978-01-25 Neue in 17-position substituierte 11beta-hydroxysteroide der pregnanreihe, ihre herstellung und verwendung
DE2855465 1978-12-19
DE19782855465 DE2855465A1 (de) 1978-12-19 1978-12-19 Neue kortikoide, verfahren zu ihrer herstellung, ihre verwendung und diese kortikoide enthaltende pharmazeutische praeparate

Publications (3)

Publication Number Publication Date
FI790240A FI790240A (fi) 1979-07-26
FI66023B FI66023B (fi) 1984-04-30
FI66023C true FI66023C (fi) 1984-08-10

Family

ID=25773724

Family Applications (1)

Application Number Title Priority Date Filing Date
FI790240A FI66023C (fi) 1978-01-25 1979-01-25 Foerfarande foer framstaellning av nya anti-inflammatoriskt vekande 11beta-hydroxisteroider

Country Status (21)

Country Link
US (1) US4207316A (fr)
EP (1) EP0003341B1 (fr)
AU (1) AU529292B2 (fr)
BG (3) BG33738A3 (fr)
CS (1) CS207753B2 (fr)
DD (2) DD150749A5 (fr)
DE (1) DE2967070D1 (fr)
DK (1) DK28779A (fr)
EG (1) EG14273A (fr)
ES (1) ES477162A1 (fr)
FI (1) FI66023C (fr)
FR (1) FR2422689A1 (fr)
GB (1) GB2014150B (fr)
IE (1) IE47729B1 (fr)
IL (1) IL56494A (fr)
NO (1) NO154583C (fr)
NZ (1) NZ189460A (fr)
PH (1) PH18164A (fr)
PT (1) PT69126A (fr)
RO (2) RO76163A (fr)
SU (6) SU876059A3 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2952003A1 (de) * 1979-12-21 1981-07-02 Schering Ag Berlin Und Bergkamen, 1000 Berlin Neue kortikoid-17-thioacetale, ihre herstellung und verwendung
DE3038855A1 (de) * 1980-10-10 1982-05-27 Schering Ag, 1000 Berlin Und 4619 Bergkamen Neue d-homo-kortikoide, ihre herstellung und verwendung
RU95115547A (ru) * 1993-01-08 1997-06-10 Астра Актиеболаг (SE) Стероидные соединения, способы их получения и фармацевтический препарат
US5502222A (en) * 1994-06-01 1996-03-26 Schering Corporation Process for preparing delta 9,11 and 21-chloro corticosteroids
US8729108B2 (en) * 2008-06-17 2014-05-20 Christopher J Dannaker Waterborne topical compositions for the delivery of active ingredients such as azelaic acid

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR6682287D0 (pt) * 1965-08-30 1973-12-04 Merck & Co Inc Processo para preparar 17-alcoxi-progesteronas
NL6605514A (fr) * 1966-04-25 1967-10-26
US3453297A (en) * 1968-07-24 1969-07-01 Merck & Co Inc 17alpha-lower alkoxy-pregna-4,6-diene-3,20-dione steroids

Also Published As

Publication number Publication date
GB2014150B (en) 1982-11-24
ES477162A1 (es) 1979-07-01
SU876060A3 (ru) 1981-10-23
PT69126A (de) 1979-02-01
IE47729B1 (en) 1984-05-30
DE2967070D1 (en) 1984-08-02
CS207753B2 (en) 1981-08-31
EP0003341B1 (fr) 1984-06-27
SU880253A3 (ru) 1981-11-07
NZ189460A (en) 1981-11-19
IE790134L (en) 1979-07-25
EP0003341A3 (en) 1979-08-22
BG33737A3 (en) 1983-04-15
SU1103797A3 (ru) 1984-07-15
FI66023B (fi) 1984-04-30
US4207316A (en) 1980-06-10
GB2014150A (en) 1979-08-22
AU4365779A (en) 1979-08-02
RO76163A (fr) 1981-08-17
EP0003341A2 (fr) 1979-08-08
BG33738A3 (en) 1983-04-15
DK28779A (da) 1979-07-26
PH18164A (en) 1985-04-09
NO154583B (no) 1986-07-28
AU529292B2 (en) 1983-06-02
SU890979A3 (ru) 1981-12-15
SU876059A3 (ru) 1981-10-23
BG33736A3 (en) 1983-04-15
RO81116A (fr) 1983-06-01
FR2422689A1 (fr) 1979-11-09
DD150749A5 (de) 1981-09-16
FI790240A (fi) 1979-07-26
IL56494A (en) 1983-02-23
EG14273A (en) 1984-06-30
NO154583C (no) 1986-11-05
SU927123A3 (ru) 1982-05-07
DD141523A5 (de) 1980-05-07
RO81116B (ro) 1983-05-30
IL56494A0 (en) 1979-03-12
NO790229L (no) 1979-07-26

Similar Documents

Publication Publication Date Title
AU657690B2 (en) Steroids which inhibit angiogenesis
AU721865B2 (en) Lactone derivatives of 17.beta.-carboxy, carbothio and amide androstane derivatives
US4172132A (en) 1,3,5(10),6,8,14-19-Nor-pregnahexaenes, their use as anti-psoriatic agents, and pharmaceutical formulations useful therefor
JP2826884B2 (ja) １７位置にアミノ置換鎖を有する新規の３―ケトステロイド、それらの製造方法及びこの方法の中間体、それらの薬剤としての使用並びにそれらを含有する製薬組成物
CZ361698A3 (cs) Deriváty androstenu a farmaceutický prostředek obsahující tyto deriváty
JPH0253440B2 (fr)
US5972922A (en) Steroids which inhibit angiogenesis
US4336200A (en) 17α-Acyloxy-5β-corticoids
JP4354809B2 (ja) 抗男性ホルモン薬剤としての１７アルファ，２１−ジヒドロキシプレグネンエステル
FI66023C (fi) Foerfarande foer framstaellning av nya anti-inflammatoriskt vekande 11beta-hydroxisteroider
US4026921A (en) D-homosteroids
US4318853A (en) 9β,11β-Epoxy-5β-corticoids
US4224320A (en) Novel steroids of the pregnane series, substituted in the 17-position, their manufacture and their use
US4427591A (en) Reduced A ring-Δ9(11) -corticoids
HU180520B (en) Process for producing 17-alpha-alkinyl derivatives of 17-beta-hydroxy-andorst-4-ene-3-one
JPS6137280B2 (fr)
JPS645880B2 (fr)
Jastrzębska et al. On reactions of steroidal 23-oxo and 23, 24-epoxysapogenins with Lewis acids
FI57600C (fi) Foerfarande foer framstaellning av nya antiinflammatoriska d-homosteroider
Fleming et al. Synthesis of nucleoside 5'-carbamates
JPH0121840B2 (fr)
EP0000609B1 (fr) 19-Nor pregnahexaènes, procédé pour leur préparation et compositions pharmaceutiques les contenant
Fétizon et al. 1, 4-Dioxene (2, 3-dihydro-1, 4-dioxine) in organic synthesis. Part 9. Preparation of biologically active side-chains from 17-oxosteroids
CA1144538A (fr) Steroides de la serie des pregnanes substitues en position 17, fabrication et utilisation
PL121296B1 (en) Process for preparing novel corticoids

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: SCHERING AKTIENGESELLSCHAFT